Buscar
Mostrando ítems 1-10 de 16
Do physicians correctly calculate thromboembolic risk scores?: a comparison of concordance between manual and computer‐based calculation of CHADS2 and CHA2DS2‐VASc scores
(Wiley, 2016-03-01)
[Abstract] BACKGROUND: Clinical risk scores, CHADS2 and CHA2 DS2 -VASc scores, are the established tools for assessing stroke risk in patients with atrial fibrillation (AF).
AIM: The aim of this study is to assess concordance ...
Usefulness of the 2MACE score to predicts adverse cardiovascular events in patients with atrial fibrillation
(Elsevier, 2017-09-19)
[Abstract] We investigated the incidence of nonembolic adverse events in 2 cohorts of patients with atrial fibrillation (AF) and validated the 2MACE score ([metabolic syndrome, age ≥75] [doubled]; [myocardial infarction ...
La INR durante los ictus y las hemorragias en pacientes con fibrilación auricular tratados con antagonistas de la vitamina K
(Elsevier, 2020-07)
[Resumen] Introducción y objetivos. La fibrilación auricular tiene un mal pronóstico asociado fundamentalmente al desarrollo de ictus. A pesar del uso de anticoagulantes, algunos pacientes pueden sufrir ictus y también ...
Relationship of Adverse Events to Quality of Anticoagulation Control in Atrial Fibrillation Patients With Diabetes: Real-World Data From the FANTASIIA Registry
(Taylor & Francis Group, 2020-06-17)
[Abstract] Background: Atrial fibrillation (AF) patients with diabetes (DM) have high risk of cardiovascular events. Purpose: To compare clinical characteristics, adverse outcomes and quality of anticoagulation in AF ...
Association of body mass index with clinical outcomes in patients with atrial fibrillation: a report from the FANTASIIA Registry
(NLM, 2019-12-24)
[Abstract]
Background.
Obesity and atrial fibrillation (AF) frequently coexist and independently increase mortality. We sought to assess the association between obesity and adverse events in patients receiving oral ...
Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A report from the FANTASIIA registry
(Wiley, 2020-10-16)
[Abstract] Background: Atrial fibrillation (AF) and peripheral artery disease (PAD) are common conditions that increase cardiovascular risk. We determined the association between PAD and prognosis in a cohort of real-world ...
Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation: the FANTASIIA study
(Elsevier, 2019-05-31)
[Abstract] Introduction and objectives: To compare the long-term results of direct oral anticoagulants (DOAC) vs vitamin K antagonists (VKA) in real-world-patients with nonvalvular atrial fibrillation (NVAF) in a nationwide, ...
Direct Anticoagulants Versus Vitamin K Antagonists in Patients Aged 80 Years or Older With Atrial Fibrillation in a “Real-world” Nationwide Registry: Insights From the FANTASIIA Study
(SAGE, 2020-03-31)
[Abstract]
Objective:
To describe major events at follow up in octogenarian patients with atrial fibrillation (AF) according to anticoagulant treatment: direct oral anticoagulants (DOACs) versus vitamin K antagonists ...
Relationship between multimorbidity and outcomes in atrial fibrillation
(Elsevier, 2021-07-23)
[Abstract] Background: Multimorbidity is common in atrial fibrillation (AF) patients. Charlson comorbidity index (CCI) is used to evaluate multimorbidity in the general population. Limited long-term data are available on ...